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Abstract
Background:  Chemokines play important roles in inflammation and antiviral action. We examined
whether polymorphisms of RANTES, IP-10 and Mig affect the susceptibility to and outcome of severe acute
respiratory syndrome (SARS).
Methods: We tested the polymorphisms of RANTES, IP-10 and Mig for their associations with SARS in
495 Hong Kong Chinese SARS patients and 578 controls. Then we tried to confirm the results in 356
Beijing Chinese SARS patients and 367 controls.
Results: RANTES -28 G allele was associated with SARS susceptibility in Hong Kong Chinese (P < 0.0001,
OR = 2.80, 95%CI:2.11–3.71). Individuals with RANTES  -28 CG and GG genotypes had a 3.28-fold
(95%CI:2.32–4.64) and 3.06-fold (95%CI:1.47–6.39) increased risk of developing SARS respectively (P <
0.0001). This -28 G allele conferred risk of death in a gene-dosage dependent manner (P = 0.014) with CG
and GG individuals having a 2.12-fold (95% CI: 1.11–4.06) and 4.01-fold (95% CI: 1.30–12.4) increased risk.
For the replication of RANTES  data in Beijing Chinese, the -28 G allele was not associated with
susceptibility to SARS. However, -28 CG (OR = 4.27, 95%CI:1.64–11.1) and GG (OR = 3.34, 95%CI:0.37–
30.7) were associated with admission to intensive care units or death due to SARS (P = 0.011).
Conclusion: RANTES -28 G allele plays a role in the pathogenesis of SARS.
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Background
Severe acute respiratory syndrome (SARS) is an infectious
disease caused by SARS coronavirus [1] with >8000 cases
and 774 deaths reported in 2003 [2]. Pathogenesis of
SARS is complex and host genetic background is one of
the factors in determining susceptibility and outcome [3].
We have demonstrated that genetic haplotypes associated
with low serum mannose-binding lectin (MBL) are associ-
ated with SARS[4] and our findings were confirmed in
another independent study [5]. We furthermore showed
that the interferon gamma gene polymorphism, +874 A/
T, is associated with SARS [6]. Other susceptibility genes,
such as liver/lymph node-specific ICAM-3-grabbing non-
integrin (L-SIGN) which is encoded by CLEC4M, 2',5'-oli-
goadenylate synthetase 1 gene (OAS-1) and myxovirus
resistance 1 (MxA) were also identified [7,8].
Chemokines play important role in cells trafficking during
immune responses. Acute respiratory viruses commonly
induce inflammatory chemokines in local tissue [9]. In
the case of SARS, our previous study confirmed that SARS
coronavirus induces upregulation of a number of inflam-
matoemokines, i.e. Regulated upon Activation, Normal T
cell-Expressed and Secreted (RANTES), interferon-gamma
inducible protein 10 (IP-10) and Monocyte Chemoat-
tractant Protein-1 (MCP-1) [10]. The upregulation of
these chemokines recruit inflammatory cells and leuko-
cytes into the tissue [11]. Therefore, we hypothesized that
the polymorphisms of inflammatory chemokine genes
might be associated with SARS.
In this study, we investigated the single nucleotide poly-
morphisms (SNPs) of inflammatory chemokine genes,
i.e.  RANTES,  IP-10  and monokine induced by gamma
interferon gene (Mig) in two Chinese cohorts from Hong
Kong and Beijing and found that the RANTES -28 G allele
was associated with disease susceptibility and severity of
SARS.
Methods
Patients
The study included 495 Hong Kong Chinese patients with
SARS. The mean ± SD age was 40.74 ± 15.73 years with
211 males and 284 females (Table 1). At least 95% of the
patients were documented with SARS-CoV antibody sero-
conversion and/or detectable SARS-CoV RNA in respira-
tory secretions by RT-PCR as described previously in our
studies [4,6]. Approval for the study was granted by the
Clinical Research Ethics Committee of the Institutional
Review Board of the University of Hong Kong/Hospital
Authority Hong Kong West Cluster. The patients were fur-
ther divided into two groups, the death group and the sur-
vival group. The death group consisted of 57 patients who
died from SARS and their mean ± SD age was 56.2 ± 15.3
years, with 33 males and 24 females. The survival group
consisted of 438 patients and their mean ± SD age was
38.7 ± 14.6 years, with 178 males and 260 females. A pop-
ulation of Hong Kong Chinese comprising 578 healthy
Red Cross blood donors served as the control subjects.
Their mean ± SD age was 30.05 ± 9.49 years, with 343
males and 235 females (Table 1).
Three hundred and fifty six Beijing Chinese patients with
SARS were recruited as described previously (mean ± SD
age = 34.85 ± 13.5, 200 male and 156 female) (Table 1)
[5]. Among them, 20 patients were classified as severe
group, which were identified by their admissions to inten-
sive care units or deaths from SARS (mean ± SD age =
39.45 ± 12.8, 11 male and 9 female). The remaining 336
patients were classified as mild group (mean ± SD age =
34.57 ± 13.5, 189 male and 147 female). A total of 367
ethnically matched healthy individuals (mean age ± SD =
32.98 ± 12.8, 200 male and 167 female) served as controls
(Table 1).
Genotyping
RANTES -28C/G (rs2107538) was genotyped by polymer-
ase chain reaction-restriction fragment length polymor-
phism (PCR-RFLP) as described previously [12].
RANTES  -403A/G (rs2107538), RANTES In1.1T/C
(rs2280789), IP-10 nt1811A/G (rs8878), IP-10 nt2867C/
A (rs4859587) and Mig nt367A/G (rs10336) were geno-
typed by the MassARRAY system (Sequenom, San Diego,
CA). In brief, the samples were amplified in a 6 μL reac-
tion mixture, containing 5 ng genomic DNA, 0.3 pmol
each of specific forward and reverse primers, 200 μL of
each dNTP, 3.25 mM MgCl2 and 0.2 units of HotStarTaq
polymerase (Qiagen, Valencia, CA). PCR conditions
included initial hot-start for 15 min at 95°C, 45 cycles of
amplification (20 sec at 95°C, 30 sec at 56°C and 1 min
at 72°C) and final extension for 3 min at 72°C. The PCR
products were treated with alkaline phosphatase to
dephosphorylate residual amplification nucleotides. A
mixture of 0.2 μL of hME buffer, 0.3 μL of shrimp alkaline
phosphatase (1 unit/μL, Sequenom) and 1.5 μL of ddH2O
was added to the PCR products. The reaction solutions
were incubated for 20 min at 37°C, followed by 5 min at
85°C to inactivate the enzyme. Mass-extend reactions to
determine genotypes were performed in four groups of
different terminations according to the design rationale
(ddACG, ddACT, ddAGT and ddCGT, respectively). The
reaction volume was 10 μL including 1 unit of Thermose-
quenase (Sequenom), 50 μM of the respective termina-
tion mix, and 0.6 pmol of each assay specific extension
primer (Table 2). All assays were run with the same ther-
mal cycle conditions: initial denaturation for 2 min at
94°C followed by 55 cycles of extension (5 sec at 94°C, 5
sec at 52°C and 5 sec at 72°C). Products of the mass-
extend reactions were desalted and transferred onto aBMC Infectious Diseases 2007, 7:50 http://www.biomedcentral.com/1471-2334/7/50
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SpectroCHIP by a nanoliter dispenser according to the
manufacturer's instructions (Sequenom).
Genotype determination was performed on a MALDI-TOF
mass spectrometer (Sequenom). Mass spectrometric data
were automatically imported into the SpectroTYPER
(Sequenom) database for data analysis including noise
normalization and peak area analysis. The expected
molecular weights of all relevant peaks were calculated by
the MassARRAY AssayDesign Software (Sequenom)
before the analysis and identified from the mass spec-
trum. In every 96-well plate for assay, there is one well for
blank control and five wells for duplicate check on five
samples for internal quality control.
Statistical Analysis
A two-step analysis was used to determine the association
of polymorphisms with SARS. The genotype frequencies
and allele frequencies of all the genes were compared
between SARS patients and controls by a 3 × 2 chi-square
test and a 2 × 2 chi-square test respectively, then logistic
regression was used for calculating odds ratios (95% con-
fidence interval) and corresponding P-values of different
genotype frequencies among SARS patients and controls
by adjusting for age, sex and all significant single nucle-
otide polymorphisms (SNPs). Association with the out-
comes of SARS infection (death vs survival) was then
tested by comparing the genotype frequencies and allele
frequencies of all the genes between the death group and
the survival group of SARS patients by a 3 × 2 chi-square
test and a 2 × 2 chi-square test respectively. The genotype
frequencies of all the SNPs were tested for Hardy-Wein-
berg equilibrium (HWE) separately in SARS patients and
controls by chi-square test. Significant P-value for multi-
ple testing was adjusted with Bonferroni's correction and
all statistical analysis was performed by SAS, version 8.02
and SAS/Genetics (SAS Institute Inc., NC, USA).
Results
RANTES -28C/G associated with SARS susceptibility in 
Hong Kong Chinese
RANTES  -28C/G,RANTES  -403A/G,  RANTES  In1.1T/C,
IP-10 nt1811A/G, IP-10 nt2867C/A and Mig nt367A/G
were genotyped in all 495 SARS patients and 578 controls
from Hong Kong. Their genotype and allele frequencies
were shown in Table 3 and 4 respectively.
RANTES  -28 CG and GG genotypes were significantly
associated with SARS susceptibility with OR of 3.28 (95%
CI: 2.32–4.64) and 3.06 (95% CI: 1.47–6.39) respectively
(P < 0.0001) (Table 3). RANTES -28 G allele was also sig-
nificantly increased in the patients (P  < 0.0001, OR =
2.80, 95%CI: 2.11–3.71) (Table 4). After correction by
Bonferroni method, the significant P value should be less
than 0.007, the association of RANTES -28C/G to SARS
susceptibility remained to have significance.
Table 2: Primers used for RANTES, IP-10, Mig polymorphisms genotyping by Sequenome
Polymorphisms Primers (5' to 3')
RANTES -403 Forward ACGTTGGATGCTGAGTCTTCAAAGTTCCTG
Reverse ACGTTGGATGAACATCCTTCCATGGATGAG
Extension CATGGATGAGGGAAAGGAG
RANTES In1.1 Forward ACGTTGGATGCACTCAGTGAACACCTGTAG
Reverse ACGTTGGATGTGCTTCATGGCAGGGATCTC
Extension TCTCCTGATCAGTTTTTCTGTCTT
IP-10 nt1811 Forward ACGTTGGATGTGGTTGAAAAAAGCAACCCC
Reverse ACGTTGGATGTAACTGAGCTTTCCTGCTGC
Extension CCTGCTGCTATGCATTC
IP-10 nt2867 Forward ACGTTGGATGTCAACCATGAAAGACTTGGG
Reverse ACGTTGGATGACCCTGATTACCAGTCAACC
Extension TCAACCTTGAAGTACAGCTATAAC
Mig nt367 Forward ACGTTGGATGTGTAGGAGAGGTTGTCTGTG
Reverse ACGTTGGATGGCACTCTAAATCATCAGCAG
Extension TCATCAGCAGTGTGAGC
Table 1: The demographic characteristics of SARSs patients and healthy controls in Hong Kong and Beijing Chinese
Hong Kong Beijing
Control (n = 578) SARS (n = 495) Control (n = 367) SARS (n = 356)
Sex (male:female) 343:235 211:284 200:156 200:167
Age (mean ± SD) 30.05 ± 9.49 40.74 ± 15.73 34.85 ± 13.5 32.98 ± 12.8BMC Infectious Diseases 2007, 7:50 http://www.biomedcentral.com/1471-2334/7/50
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All genotype frequencies of the six polymorphisms in
SARS patients and controls were in HWE except for the
RANTES -28C/G in controls. To confirm that there is no
genotyping error that may contribute to the observation
in HWE, direct DNA sequencing was performed in 20–30
samples for each SNP and no ambiguous results were
obtained.
RANTES -28C/G associated with death of Hong Kong 
Chinese patients
We then compared the genotype and allele frequencies of
the RANTES -28C/G between the death group and sur-
vival group of the SARS patients. RANTES -28 G allele
associated with death from SARS in a gene-dosage
dependent manner (P = 0.014), with -28 CG and GG indi-
viduals having a 2.12-fold (95% CI: 1.11–4.06) and 4.01-
fold (95% CI: 1.30:12.4) increased risk of death from
SARS respectively (Table 5).
Association of RANTES -28 C/G with SARS in Beijing 
Chinese
To further confirm the association of RANTES with SARS,
we studied the three RANTES SNPs in a Beijing Chinese
cohort [14]. Three hundred and fifty six SARS patients and
367 healthy controls were genotyped and their genotype
and allele frequencies were shown in (Table 6). All geno-
type distributions of the two groups were in HWE. No sig-
nificant difference was observed between the frequencies
in the SNPs between patients and controls.
Next, we investigated the association of RANTES -28C/G
with SARS severity. Twenty patients were classified as
severe group as defined by their admissions to intensive
care units or deaths due to SARS [5]. The genotype and
allele frequencies of this SNP in severe and mild patients
were shown in Table 7. The genotype distribution among
the two groups were significantly different (P = 0.011).
The frequencies of CG and GG genotypes were over-repre-
sented in the severe group (CG: OR = 4.27, 95%CI: 1.64–
11.1; GG: OR = 3.34, 95%CI: 0.37–30.7). The frequency
of G allele was also significantly increased in the severe
group (OR = 2.78, 95%CI: 1.37–5.63, P = 0.005).
Discussion
We described here that Hong Kong Chinese with RANTES
-28CG and GG genotypes had a 3.28-fold (95% CI: 2.32–
4.64) and 3.06-fold (95% CI: 1.47–6.39) increased risk of
developing SARS respectively (P < 0.0001) (Table 3). This
-28 G allele also increased the risk of death of Hong Kong
Chinese patients with SARS in a gene-dosage dependent
Table 3: Genotype frequencies in Hong Kong Chinese patients and controls*
SNP Control (n = 578) SARS (n = 495) OR (95% CI) P
Number (%)
Genotype
RANTES -403 NS
AA 56 (9.7) 54 (10.9)
AG 262 (45.3) 223 (45.0)
GG 260 (45.0) 218 (44.0)
RANTES -28 <0.0001
CC 491 (84.9) 316 (63.8) Reference
CG 73 (12.6) 154 (31.1) 3.28 (2.32 – 4.64)
GG 14 (2.4) 25 (5.0) 3.06 (1.47 – 6.39)
RANTES ln1.1 NS
CC 54 (9.3) 54 (10.9)
CT 257 (44.5) 217 (43.8)
TT 267 (46.2) 224 (45.3)
IP-10 nt1811 NS
AA 0 (0) 1 (0.2)
AG 29 (5.0) 38 (7.7)
GG 549 (95.0) 456 (92.1)
IP-10 nt2867 NS
AA 0 (0) 1 (0.2)
AC 31 (5.4) 38 (7.7)
CC 547 (94.6) 456 (92.1)
Mig nt367 NS
AA 0 (0) 1 (0.2)
AG 34 (5.9) 38 (7.7)
GG 544 (94.1) 456 (92.1)
NS = not significant.
*P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age. After correction by Bonferroni 
method, the significant P value should be less than 0.007BMC Infectious Diseases 2007, 7:50 http://www.biomedcentral.com/1471-2334/7/50
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manner (P = 0.014) that -28 CG and GG individuals had
a 2.12-fold (95% CI: 1.11–4.06) and 4.01-fold (95% CI:
1.30:12.4) increased risk (Table 5). More importantly, we
further confirmed the association of RANTES  -28 C/G
with the severity of SARS by studying the Beijing Chinese
cohort and found that Beijing Chinese patients with CG
(OR = 4.27, 95%CI: 1.64–11.1) and GG (OR = 3.34,
95%CI: 0.37–30.7) genotype were more severe, as defined
by admission to intensive care units or deaths due to
SARS. To further investigate the association of RANTES
with SARS, we have also performed haplotype analysis
using the 3 studied SNPs of RANTES, i.e. -403A/G, -28C/
G and In1.1T/C, for constructing the haplotypes. How-
ever, the major effect of the haplotypes was due to the SNP
RANTES -28 only (data not shown).
RANTES is responsible for the recruitment of eosinophils,
lymphocytes, monocytes and basophils at the site of
inflammation and is involved in many viral infections
[13,14]. We found that -28 G allele of RANTES associated
with the susceptibility to and death from SARS. Indeed,
RANTES  -28C/G is located at the NF-κB binding site,
which is confirmed by gel-mobility shift assays [15],
meaning that this SNP may be involved in the regulation
of RANTES expression. Further in vitro studies show that
RANTES -28 G allele enhances NF-κB binding that leads
to elevation of promoter activity and increases RANTES
expression in CD8+ T cells, CD4+ T cells and monocytes/
macrophages [15,16]. Therefore, together with our obser-
vation that -28 G allele associated with SARS, we conclude
Table 4: Allele frequencies in Hong Kong Chinese patients and controls*
SNP Control (n = 578) SARS (n = 495) OR (95% CI) P
Number (%)
Allele
RANTES -403 NS
A 374 (32.4) 331 (33.4)
G 782 (67.7) 659 (66.6)
RANTES -28 <0.0001
C 1055 (91.3) 786 (79.4)
G 101 (8.7) 204 (20.6) 2.80 (2.11 – 3.71)
RANTES ln1.1 NS
C 365 (31.6) 325 (32.9)
T 791 (68.4) 665 (67.2)
IP-10 nt1811 NS
A 29 (2.5) 40 (4.0)
G 1127 (97.5) 950 (96.0)
IP-10 nt2867 NS
A 31 (2.7) 40 (4.0)
C 1125 (97.3) 950 (96.0)
Mig nt367 NS
A 34 (2.9) 40 (4.1)
G 1122 (97.1) 938 (95.9)
NS = not significant.
*P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age. After correction by Bonferroni 
method, the significant P value should be less than 0.007
Table 5: Genotype and allele frequencies of RANTES -28C/G among death and survival groups in Hong Kong Chinese*
Death (n= 57) Survival (n = 438) OR (95% CI) P
Number (%)
RANTES -28C/G
Genotype 0.014
CC 26 (45.6) 290 (66.2) Reference
CG 25 (43.9) 129 (29.5) 2.12 (1.11 – 4.06)
GG 6 (10.5) 19 (4.3) 4.01 (1.30 – 12.4)
Allele 0.002
C 77 (67.5) 709 (80.9)
G 37 (32.5) 167 (19.1) 2.10 (1.30 – 3.39)
NS = not significant.
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age.BMC Infectious Diseases 2007, 7:50 http://www.biomedcentral.com/1471-2334/7/50
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a high level of RANTES may predispose to developing
SARS.
This study showed that RANTES -28 G allele was a risk fac-
tor that associated with severe clinical outcomes in both
Hong Kong and Beijing Chinese SARS patients. It has to
be noted that many cytokines/chemokines released from
activated immune cells not only take part in the process of
anti-viral immune response, but are also involved in cell
damage and organ dysfunction [17]. Apart from the
chemokine receptor signaling pathway, RANTES could
activate T cells through herbimycin A-sensitive protein
tyrosine kinase (PTK)-mediated pathway at high concen-
tration [18]. This triggers the release of inflammatory
cytokines and chemokines such as IL-2, IL-5, IFN-γ and
MIP1-β [18]. We have recently demonstrated SARS coro-
navirus can induce high level of expression of chemokines
from human dendritic cells [10]. Too high a level of
RANTES may intensify lung inflammation and lead to
lymphopenia, increasing the chance of secondary infec-
tion and hence death rate among SARS patients [18,19].
Therefore, we speculate that the -28 G allele that associates
with the higher level of RANTES may enhance the inflam-
mation and lead to severe clinical outcomes of SARS.
Table 6: Genotype and allele frequencies of RANTES -28C/G in Beijing Chinese patients and controls*
SNP Control (n = 367) SARS (n = 356) OR (95% CI) P
Number (%)
Genotype
RANTES -403 NS
AA 60 (16.4) 62 (17.4)
AG 160 (43.6) 153 (43.0)
GG 147 (40.1) 141 (39.6)
RANTES -28 NS
CC 273 (74.4) 258 (72.5)
CG 83 (22.6) 87 (24.4)
GG 11 (3.0) 11 (3.1)
RANTES ln1.1 NS
CC 54 (14.7) 63 (17.7)
CT 162 (44.1) 152 (42.7)
TT 151 (41.1) 141 (39.6)
Allele
RANTES -403 NS
A 280 (38.2) 277 (38.9)
G 454 (61.9) 435 (61.1)
RANTES -28 NS
C 629 (85.7) 603 (84.7)
G 105 (14.3) 109 (15.3)
RANTES ln1.1 NS
C 270 (36.8) 278 (39.0)
T 464 (63.2) 434 (60.9)
NS = not significant.
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age.
Table 7: Genotype and allele frequencies of RANTES -28C/G among severe and mild groups in Beijing Chinese*
Severe (n = 20) Mild (n = 336) OR (95% CI) P
Number (%)
RANTES -28C/G
Genotype 0.011
CC 8 (40.0) 250 (74.4) Reference
CG 11 (55.0) 76 (22.6) 4.27 (1.64 – 11.1)
GG 1 (5.0) 10 (2.98) 3.34 (0.37 – 30.7)
Allele 0.005
C 27 (67.5) 576 (85.7)
G 13 (32.5) 96 (14.3) 2.78 (1.37 – 5.63)
NS = not significant.
P-value and OR (95% CI) were calculated with the use of logistic regression models, adjusted with sex and age.BMC Infectious Diseases 2007, 7:50 http://www.biomedcentral.com/1471-2334/7/50
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Indeed, RANTES -28 G allele did show a strong associa-
tion with death in Hong Kong Chinese patients with SARS
(Table 5) and this observation was confirmed in Beijing
Chinese that the RANTES -28 G allele was associated with
admission to intensive care units or deaths due to SARS
(Table 7).
In the case of SARS susceptibility, the RANTES -28 G allele
was associated with Hong Kong Chinese patients only but
not in Beijing Chinese patients. It has been suggested that
Chinese in southern and northern China may be geneti-
cally distinct [20,21], accounting for the different observa-
tions with regard to SARS susceptibility.
Conclusion
We demonstrated that the RANTES -28 G allele, which
correlates with high RANTES production, was associated
with SARS susceptibility in Hong Kong Chinese. It was
also associated with adverse outcomes from SARS in both
Hong Kong and Beijing Chinese. These suggest that a high
RANTES level may play a role in the pathogenesis of SARS.
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